The present invention relates to providing a platform for predictive modeling of changes in composition of microbial communities upon exposure to changes or perturbations in the environment, more specifically the introduction of antimicrobial compounds, bacteriophages, or other agents that can be used for targeted or personalized therapy or microbiome remodeling. This platform has applications for human and animal health as well as environmental purposes.